UBS AM’s Medidata Solutions, Inc. MDSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-81,482
Closed -$7.46M 2952
2019
Q3
$7.46M Buy
81,482
+14,432
+22% +$1.32M 0.01% 1056
2019
Q2
$6.07M Buy
67,050
+17,977
+37% +$1.58M ﹤0.01% 1132
2019
Q1
$3.59M Buy
49,073
+5,951
+14% +$429K ﹤0.01% 1267
2018
Q4
$2.91M Buy
43,122
+4,418
+11% +$312K ﹤0.01% 1282
2018
Q3
$2.84M Sell
38,704
-48
-0.1% -$3.84K ﹤0.01% 1356
2018
Q2
$3.12M Sell
38,752
-137
-0.4% -$10.3K ﹤0.01% 1324
2018
Q1
$2.44M Buy
38,889
+1,068
+3% +$71.1K ﹤0.01% 1388
2017
Q4
$2.4M Buy
37,821
+1,639
+5% +$117K ﹤0.01% 1355
2017
Q3
$2.82M Buy
36,182
+4,046
+13% +$308K ﹤0.01% 1269
2017
Q2
$2.51M Buy
32,136
+2,412
+8% +$168K ﹤0.01% 1271
2017
Q1
$1.71M Buy
29,724
+4,251
+17% +$230K ﹤0.01% 1410
2016
Q4
$1.26M Sell
25,473
-13,212
-34% -$686K ﹤0.01% 1467
2016
Q3
$2.16M Buy
38,685
+3,754
+11% +$199K ﹤0.01% 1349
2016
Q2
$1.64M Buy
34,931
+2,289
+7% +$99.7K ﹤0.01% 1428
2016
Q1
$1.26M Sell
32,642
-7,525
-19% -$292K ﹤0.01% 1549
2015
Q4
$1.98M Buy
40,167
+1,605
+4% +$70.6K ﹤0.01% 1444
2015
Q3
$1.62M Buy
38,562
+9,364
+32% +$476K ﹤0.01% 1519
2015
Q2
$1.59M Buy
29,198
+9,600
+49% +$515K ﹤0.01% 1496
2015
Q1
$961K Buy
19,598
+900
+5% +$41.7K ﹤0.01% 1648
2014
Q4
$893K Buy
18,698
+1,000
+6% +$43.3K ﹤0.01% 1636
2014
Q3
$784K Sell
17,698
-89,700
-84% -$3.97M ﹤0.01% 1649
2014
Q2
$4.6M Buy
107,398
+86,700
+419% +$3.6M ﹤0.01% 1050
2014
Q1
$1.12M Buy
20,698
+500
+2% +$30.5K ﹤0.01% 1528
2013
Q4
$1.22M Buy
20,198
+3,600
+22% +$199K ﹤0.01% 1448
2013
Q3
$821K Hold
16,598
﹤0.01% 1577
2013
Q2
$643K Buy
+16,598
New +$541K ﹤0.01% 1607

Other funds holding MDSO

UBS AM's MDSO Position: Q4 2019 in Review

UBS AM sold out of Medidata Solutions, Inc. (MDSO) in Q4 2019, closing a stake of 81,482 shares — an estimated $7.46M sold.

UBS AM first reported a position in MDSO in Q2 2013 and held it in 26 quarters. The position peaked at $7.46M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDSO as of Q4 2019.

  • UBS AM reported no remaining Medidata Solutions, Inc. position as of Q4 2019 after selling out during the quarter.
  • UBS AM sold 81,482 Medidata Solutions, Inc. shares in Q4 2019, an estimated $7.46M.
  • UBS AM first reported a position in Medidata Solutions, Inc. in Q2 2013 and held it in 26 quarters.
  • UBS AM's Medidata Solutions, Inc. position peaked at $7.46M in Q3 2019.
  • 1 fund tracked by Wall St. Rank held Medidata Solutions, Inc. as of Q4 2019.

Based on UBS AM's 13F filing for Q4 2019, filed 14 Feb 2020.